Literature DB >> 24658308

Antibacterial drugs: Redesigned antibiotic combats drug-resistant tuberculosis.

Megan Cully.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24658308     DOI： 10.1038/nrd4287

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux.

Authors:  Richard E Lee; Julian G Hurdle; Jiuyu Liu; David F Bruhn; Tanja Matt; Michael S Scherman; Bernd Meibohm; Erik C Böttger; Anne J Lenaerts; Pavan K Vaddady; Zhong Zheng; Jianjun Qi; Rashid Akbergenov; Sourav Das; Dora B Madhura; Chetan Rathi; Ashit Trivedi; Cristina Villellas; Robin B Lee; Samanthi L Waidyarachchi; Dianqing Sun; Michael R McNeil; Jose A Ainsa; Helena I Boshoff; Mercedes Gonzalez-Juarrero
Journal:  Nat Med       Date:  2014-01-26       Impact factor: 53.440
  1 in total
  3 in total

1.  Isolation and complete genome sequence of a novel virulent mycobacteriophage, CASbig.

Authors:  Tieshan Teng; Junping Yu; Hang Yang; Hongping Wei
Journal:  Virol Sin       Date:  2015-02       Impact factor: 4.327

2.  Molecular Quantum Similarity, Chemical Reactivity and Database Screening of 3D Pharmacophores of the Protein Kinases A, B and G from Mycobacterium tuberculosis.

Authors:  Alejandro Morales-Bayuelo
Journal:  Molecules       Date:  2017-06-21       Impact factor: 4.411

3.  Developing synergistic drug combinations to restore antibiotic sensitivity in drug-resistant Mycobacterium tuberculosis.

Authors:  Charles Omollo; Vinayak Singh; Elizabeth Kigondu; Antonina Wasuna; Pooja Agarwal; Atica Moosa; Thomas R Ioerger; Valerie Mizrahi; Kelly Chibale; Digby F Warner
Journal:  Antimicrob Agents Chemother       Date:  2021-02-22       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.